Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
DC: Do Measurable Changes in Brain Function Herald Dementia?
23 November 2011. Some successful Alzheimer’s disease treatments may hinge on predicting who will get disease before they present with symptoms. To that end, many research groups are exploring biomarkers, cognitive tests, and brain imaging as possible ways to spot at-risk individuals before they show neuronal damage or mental deficits. Two functional imaging studies presented at this year’s Society for Neuroscience meeting, held 12-16 November in Washington, DC, suggest that underlying brain function during working memory tasks could herald cognitive decline even while performance on cognitive tests still looks completely normal.

Julie Dumas and colleagues at the University of Vermont in Burlington reported at a November 14 SfN press conference that post-menopausal women with cognitive complaints activate larger portions of their working memory centers when performing a working memory task than those who do not complain of cognitive difficulties. Through a series of questionnaires, the research team categorized 23 post-menopausal women with an average age of 57 years as “complainers” or “non-complainers.” Functional magnetic resonance imaging (fMRI) revealed that, although the 12 complainers performed as well as their content counterparts on a visual/verbal test of working memory, more of the complainers’ dorsolateral prefrontal cortices and anterior cingulate cortices were active.

“We believe that this is a compensation response,” said Dumas. “These cognitive complainers are activating brain regions involved in working memory to a greater extent than non-complainers.” Previous work from Reisa Sperling’s lab at Brigham and Women’s Hospital, Boston, suggested a hyperactivation of the hippocampus, which may also reflect a compensatory mechanism (see Celone et al., 2006).

A previous longitudinal study on a mixed-gender sample of 213 people with an average age of 67 reported that 54 percent of people complaining of cognitive difficulties progressed to mild cognitive impairment (MCI) or dementia within seven years, even though they performed normally on initial cognitive testing. Only 15 percent of those without complaints showed such decline (see Reisberg et al., 2010). The results hint that subjective cognitive impairment is a risk factor for dementia—people may not just be imagining cognitive difficulties. While other factors can account for cognitive problems, Dumas said she controlled for depression, sleep deprivation, and hot flashes in her study and still found differences between groups.

Other studies suggest that the hippocampus in older adults is smaller in cognitive complainers compared to non-complainers (see Stewart et al., 2011 and van der Flier et al., 2004).

“We’re now showing that these cognitive complaints are important around the age of menopause. We suggest they may be related to future cognitive changes,” said Dumas. She plans to follow these women, half of whom will be treated for three months with estrogen and half with placebo, to see if estrogen mitigates the functional differences between the two groups.

In a related poster presentation by Lucas Broster, a graduate student in the lab of Yang Jiang at the University of Kentucky College of Medicine in Lexington, described a pilot study that used functional data to differentiate between people with MCI and healthy controls in a mixed-gender, older cohort. Broster reported that while people with MCI performed just like healthy controls on a working memory task, electroencephalography (EEG) measurements distinguished the two groups (see Part 1 of a two-part series on EEG).

The research team tested 46 people (average age, 76)—either normal controls or diagnosed with MCI or AD—on a delayed match-to-sample test. Participants memorized an image and then determined whether the following images matched. Cognitively healthy people took the same amount of effort to accept or reject an image. However, individuals with MCI had to work harder to reject an image than they did to accept it, as shown by EEG-measured event related potentials in the left frontal brain. Preliminary data suggest that those with AD also had to work harder to reject an image, though Broster cautioned that these data are not significant in the small number of AD patients studied so far. The team will collect more results to see if the trend holds up. “Differentiating healthy patients versus those with MCI is clinically challenging,” said Broster. “If we find that the task is as sensitive as our pilot data imply, it could have some translational potential for screening people for MCI.”—Gwyneth Dickey Zakaib.

 
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad